Dexbudesonide
| Dexbudesonide | |
|---|---|
| Dexbudesonide.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dexbudesonide is a synthetic glucocorticoid used primarily in the management of various inflammatory conditions. It is a derivative of budesonide, a well-known corticosteroid, and is utilized for its potent anti-inflammatory properties.
Pharmacology[edit]
Dexbudesonide functions by binding to the glucocorticoid receptor, which leads to the modulation of gene expression. This results in the suppression of inflammatory cytokines and mediators, thereby reducing inflammation and immune response. The drug is known for its high topical efficacy and low systemic bioavailability, which minimizes systemic side effects.
Medical uses[edit]
Dexbudesonide is used in the treatment of several conditions, including:
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis
Side effects[edit]
Common side effects of dexbudesonide include:
Less common but more serious side effects can include:
Mechanism of action[edit]
Dexbudesonide exerts its effects by interacting with the glucocorticoid receptor in the cytoplasm of cells. Upon binding, the receptor-ligand complex translocates to the nucleus, where it influences the transcription of anti-inflammatory proteins and inhibits the transcription of pro-inflammatory genes.
Administration[edit]
Dexbudesonide is available in various forms, including inhalers, nasal sprays, and oral tablets. The route of administration is chosen based on the condition being treated and the desired site of action.
Related pages[edit]
-
Dexbudesonide
